So Prenetics (PRE) just authorized a $40 million share repurchase program over the next year, which is interesting timing. What caught my eye though is that executives have been dumping their own money into this - CEO Danny Yeung alone bought around $750k worth in late February, and the team collectively put in like $2.75 million of personal capital since November. That's the kind of insider confidence you actually want to see, not just empty words. When management is willing to back their own company with real money, a share repurchase program hits different. It's basically saying they think the stock is undervalued at current levels. PRE was up 7.33% to $16.23 when this dropped on Nasdaq. The combination of insider purchases plus the repurchase authorization suggests they're pretty bullish on where this is headed. Not financial advice obviously, but that's the kind of signal worth paying attention to when you're evaluating a company.